Prevention of the Complications of Bleeding Disorders Through Hemo Tmt Centers

通过血液 TMT 中心预防出血性疾病并发症

基本信息

  • 批准号:
    7232160
  • 负责人:
  • 金额:
    $ 42.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2011-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Region IV South Bleeding Disorders Program is a network of nine federally funded Hemophilia Treatment Centers (HTCs) that provide comprehensive care and prevention services to persons with bleeding disorders in the states of Alabama, Florida, Georgia, and Mississippi. The Regional Core Center (RCC) office is located in Atlanta, Georgia and shares an office with Hemophilia of Georgia, Inc. The RCC emphasizes a pro-active orientation toward bleeding disorder care. This program will further the mission of the CDC in promoting heath and quality of life in persons with bleeding disorders by preventing and controlling disease, injury and disability. The goals and objectives of this regional program were designed to reduce the complications and morbidity associated with bleeding disorders, as well as to promote access to integrated and family-centered services for individuals with bleeding disorders in Region IV South. Comprehensive systems of care are necessary, as those receiving care outside of an HTC have a 60% higher mortality rate than those receiving care in federally funded HTCs (CDC). Objectives will focus on those patients from traditionally underserved populations. Prevention programs will strive to reduce the impact on the public health system by, for example, decreasing the number of days missed from work and school. The RCC will be responsible for program evaluation and monitoring through required affiliate reporting, data reports, assessment of Universal Data Collection (UDC) Project participation, site visits, needs assessments, and consumer input. Other specific project objectives include: (1) provide continuous screening for HIV and Hepatitis A, B, and C; (2) facilitate improved regional information management systems, data collection and evaluation; (3) expand the UDC cohort through recruitment of individuals with genetic bleeding disorders; (4) transition the national database to a web-based application; (5) expand the database with additional relevant date related to women's issues and other important clinical outcomes; and (6) address areas of concern unique to Region IV South regarding healthcare disparities. This hemophilia care program strives to improve the quality and years of healthy lives for those living with bleeding disorders in Region IV South. Prevention and outreach efforts aimed at the traditionally underserved will eliminate the region's health disparities by providing quality healthcare services, regardless of an individual's race, ethnicity, age, or gender. Particular attention will be paid to the leading health indicators: physical activity, overweight and obesity, immunization and access to health care.
描述(由申请人提供):第四区南部出血性疾病计划是一个由九个联邦资助的血友病治疗中心 (HTC) 组成的网络,为阿拉巴马州、佛罗里达州、佐治亚州和密西西比州的出血性疾病患者提供全面的护理和预防服务。区域核心中心 (RCC) 办公室位于佐治亚州亚特兰大,与佐治亚州血友病公司共用一个办公室。RCC 强调积极主动地进行出血性疾病护理。该计划将进一步推进 CDC 的使命,即通过预防和控制疾病、伤害和残疾来促进出血性疾病患者的健康和生活质量。该区域计划的目的和目标旨在减少与出血性疾病相关的并发症和发病率,并促进第四区南部出血性疾病患者获得综合和以家庭为中心的服务。全面的护理系统是必要的,因为在 HTC 之外接受护理的人的死亡率比在联邦资助的 HTC (CDC) 中接受护理的人高 60%。目标将集中于那些传统上服务不足的人群的患者。预防计划将努力减少对公共卫生系统的影响,例如减少缺勤和缺课的天数。 RCC 将负责通过所需的附属报告、数据报告、通用数据收集 (UDC) 项目参与评估、实地考察、需求评估和消费者意见来进行项目评估和监控。其他具体项目目标包括: (1) 提供艾滋病毒和甲型、乙型和丙型肝炎的持续筛查; (二)促进完善区域信息管理系统、数据收集和评估; (3) 通过招募患有遗传性出血性疾病的个体来扩大 UDC 队列; (4) 将国家数据库转变为基于网络的应用程序; (5) 扩大数据库,增加与妇女问题和其他重要临床结果相关的数据; (6) 解决第四区南部特有的医疗保健差异问题。该血友病护理计划致力于提高第四区南部出血性疾病患者的质量和健康生活年限。针对传统上服务不足的人群的预防和外展工作将通过提供优质的医疗保健服务来消除该地区的健康差距,无论个人的种族、民族、年龄或性别如何。将特别关注主要健康指标:体力活动、超重和肥胖、免疫接种和获得医疗保健的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRICIA DOMINIC其他文献

PATRICIA DOMINIC的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRICIA DOMINIC', 18)}}的其他基金

Prevention of the Complications of Bleeding Disorders Through Hemo Tmt Centers
通过血液 TMT 中心预防出血性疾病并发症
  • 批准号:
    7487541
  • 财政年份:
    2006
  • 资助金额:
    $ 42.64万
  • 项目类别:
Prevention of the Complications of Bleeding Disorders Through Hemo Tmt Centers
通过血液 TMT 中心预防出血性疾病并发症
  • 批准号:
    7279184
  • 财政年份:
    2006
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401895
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401889
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401894
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401892
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401890
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401891
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401887
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:
PREVENTION OF THE COMPLICATIONS OF HEMOPHILIA THROUGH HTCS
通过 HTCS 预防血友病并发症
  • 批准号:
    7401886
  • 财政年份:
    1996
  • 资助金额:
    $ 42.64万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.64万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 42.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了